Skip to NavigationSkip to content

Business Services

Ayala hires AbbVie’s Gary Gordon as new CMO

Published on: 10/09/19

AbbVie’s former Vice President of Oncology has moved to Ayala Pharmaceuticals to work as its new Chief Medical Officer (CMO). 

Israel-based startup Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies for people living with genetically defined cancers – it is currently working on the development of its pan-Notch inhibitor AL101, currently in Phase 2 in adenoid cystic carcinoma (ACC).

Trump’s FDA: Is the US regulator being steered by the President?

Published on 09/09/19 at 12:27pm

FDA activity has fallen under Donald Trump, with the number of warning letters issued by the regulator dropping by a third since the President took office, according to a recent article published in Science. Louis Goss asks whether the current administration is affecting the direction of the organisation, or is it mostly independent of federal oversight?

Top Ten most popular articles on Pharmafile.com this week

It's Friday, meaning the weekend is within reach and it's time for a rundown of the most popular articles on Pharmafile.com over the past seven days:

10. Ireland will not suffer immediate medicine shortages in event of no-deal Brexit, says health authority

Key legal considerations in accelerating pharma using artificial intelligence

Published on 04/09/19 at 12:55pm

Charlotte Walker-Osborn, Partner and International Technology Sector Head and Nabil Asaad, Senior Associate, Intellectual Property Law Group – both from global law firm Eversheds Sutherland – discuss the intricacies of pharma/AI partnerships, including data privacy, cyber security, and intellectual property concerns.

Recent advances in the development of artificial intelligence (AI), coupled with the availability of sufficient computing power to enable their effective use, have now made the application of AI methods to pharmaceutical R&D a realistic prospect.

FREE WEBINAR: Leveraging technology for optimal engagement

Join Pharmafocus and Within3 for a special webinar event on Thursday, 19 September, for a session exploring the changing trends in engagement environments throughout the industry.

During the webinar, titled ‘Leveraging technology for optimal engagement’, Pharmafocus will be joined by Within3 Managing Director Andy Bowman,  who will delve into the key components of an effective engagement platform and how technology eliminates logistical hurdles while yielding deeper, more actionable insights.

Top Ten most popular articles on Pharmafile.com this week

Happy Friday! It's time for another rundown of the top 10 most popular articles with Pharmafile.com readers this week.

10. NICE Chief Sir Andrew Dillon to step down in 2020

It’s the end of an era at NICE as its Chief Executive Sir Andrew Dillon announces that he will step down from his role at the end of March next year.

Using advanced digital capabilities to unlock hard-to-see HCPs access

Pharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their channel preferences and ensure they are getting relevant information in a timely manner.

Working Life: Linda Armstrong, Global Head, Respiratory Development Unit at Novartis

Published on 27/08/19 at 12:16pm

Linda Armstrong, Global Head, Respiratory Development Unit at Novartis.

FibroGen rocked by unexpected death of CEO Thomas B Neff

In a saddening turn of events, San Francisco-based FibroGen has announced that Thomas B Neff, its Chief Executive Officer and Chairman of the Board of Directors, unexpectedly passed away over the weekend.

The company released a statement alongside the news which praised Neff for a “legacy of innovation and dedication that has been rarely matched in this industry”.

Four perspectives from life sciences companies on multichannel engagement

By 2020, 70% of HCPs are expected to be digital natives, whose experiences with mobile, social, and digital technologies in their personal lives raise their expectations for business interactions. As more channels become available to HCPs, life sciences companies must adapt their approach to engaging with these customers.

Hear four perspectives from life sciences companies on how they are approaching multichannel engagement: 

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches